William E. Delaney
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, Liver Disease Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆(2004)896 cited
- → Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase(2003)567 cited
- → Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus(2006)261 cited
- → The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro(2003)259 cited
- → Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1 1Gilead Sciences gratefully acknowledges the patients, investigators, and study site personnel who participated in clinical trials GS-98-437 and GS-98-438.(2003)223 cited
- → In Vitro Susceptibility of Adefovir-Associated Hepatitis B Virus Polymerase Mutations to other Antiviral Agents(2007)178 cited
- → Cross-Resistance Testing of Next-Generation Nucleoside and Nucleotide Analogues against Lamivudine-Resistant HBV(2005)170 cited
- → Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks(2002)169 cited
- → A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook(2022)163 cited
- → Phenylpropenamide Derivatives AT-61 and AT-130 Inhibit Replication of Wild-Type and Lamivudine-Resistant Strains of Hepatitis B Virus In Vitro(2002)156 cited